A detailed history of Fiduciary Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fiduciary Financial Group, LLC holds 1,688 shares of ABBV stock, worth $382,956. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,688
Previous 1,512 11.64%
Holding current value
$382,956
Previous $287 Million 36.06%
% of portfolio
0.06%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 09, 2025

BUY
$184.85 - $231.54 $32,533 - $40,751
176 Added 11.64%
1,688 $391 Million
Q2 2025

Jul 02, 2025

SELL
$170.16 - $206.27 $23,822 - $28,877
-140 Reduced 8.47%
1,512 $287 Million
Q1 2025

Apr 14, 2025

SELL
$169.2 - $216.66 $2,707 - $3,466
-16 Reduced 0.96%
1,652 $288 Million
Q4 2024

Jan 13, 2025

BUY
$164.99 - $203.87 $33,162 - $40,977
201 Added 13.7%
1,668 $292 Million
Q3 2024

Oct 09, 2024

BUY
$163.84 - $199.33 $240,353 - $292,417
1,467 New
1,467 $283 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $401B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fiduciary Financial Group, LLC Portfolio

Follow Fiduciary Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Financial Group, LLC with notifications on news.